ABBV - AbbVie Inc.
233.86
-0.400 -0.171%
Share volume: 6,548,207
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$234.26
-0.40
0.00%
Summary score
58%
Profitability
59%
Dept financing
50%
Liquidity
38%
Performance
65%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
1.73%
Return on sales
24.06%
Return on invested capital
0%
Total debt ratio
94.09%
Debt ratio change over timeo
17.33%
Current Ratio
0.82%
Quick Ratio
0.71%
Cash Position Ratio
0.25%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
1.7%
Return on sales
24.78%
Return on invested capital
0%
Total debt ratio
100.88%
Debt ratio change over timeo
0%
Current Ratio
0.72%
Quick Ratio
0.6%
Cash Position Ratio
0.14%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
2.48%
Return on sales
27.34%
Return on invested capital
0%
Total debt ratio
102.44%
Debt ratio change over time
0%
Current Ratio
0.67%
Quick Ratio
0.56%
Cash Position Ratio
0.12%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-21.02%
Return on sales
620.76%
Return on invested capital
0%
Total debt ratio
1733.42%
Debt ratio change over time
17.33%
Current Ratio
15.86%
Quick Ratio
13.65%
Cash Position Ratio
2.88%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABBV | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | 1.73% | 4.74% | 3.19% | 0% |
| Return on sales | 24.06% | 30.88% | 25.28% | 0% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 29% | 93% | 84% | 0% |
| Total debt ratio | 94.09% | 80.37% | 59.38% | 0% |
| Debt ratio change over time | 17.33% | -20.57% | -85.61% | 0% |
| Dept financing | 50% | 21% | 16% | 0% |
| Current Ratio | 0.72% | 1.44% | 1.09% | 0% |
| Quick Ratio | 0.6% | 1.12% | 0.84% | 0% |
| Cash Position Ratio | 0.14% | 0.16% | 0.44% | 0% |
| Liquididy | 48% | 58% | 73% | 0% |
| Short-term ratios | ABBV | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 1.7% | 6.06% | 4.18% | 0% |
| Return on sales | 24.78% | 39.61% | 26.91% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 73% | 50% | 34% | 0% |
| Total debt ratio | 100.88% | 80% | 59.26% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 20% | 15% | 0% |
| Current Ratio | 0.72% | 1.44% | 1.09% | 0% |
| Quick Ratio | 0.6% | 1.12% | 0.84% | 0% |
| Cash Position Ratio | 0.14% | 0.16% | 0.44% | 0% |
| Liquididy | 34% | 59% | 63% | 0% |